









市場行情
/
股票
/
nasdaq-wgs
/

GeneDx Holdings Corp

WGS

90.900USD

+11.190+14.04%

收盤 06/24, 16:00（美東）報價延遲15分鐘

2.59B總市值

虧損本益比TTM



GeneDx Holdings Corp

90.900

+11.190+14.04%

GeneDx Holdings Corp. 是一家基因組學公司。該公司專注於提供個性化和可操作的健康見解，以指導診斷、指導治療和改善藥物發現。該公司的部門包括 GeneDx，包括 Legacy GeneDx 和 Legacy Sema4。GeneDx 部門主要提供兒科和罕見疾病診斷，重點是全外顯子組和基因組測序，以及在較小程度上提供數據和信息服務。GeneDx 利用集成的實驗室流程、軟件工具和信息學功能組合來處理含脫氧核糖核酸 (DNA) 的樣本，分析有關患者特定遺傳變異的信息併爲臨牀醫生及其患者生成測試報告。GeneDx 提供各種基因診斷測試、篩查解決方案和信息。Legacy Sema4 診斷部門提供生殖和女性健康以及軀體腫瘤診斷測試和篩查產品。

公司簡介

公司代碼WGS

公司名稱GeneDx Holdings Corp

上市日期Sep 04, 2020

成立日期2020

CEOMs. Katherine A. Stueland

員工數量1000

證券類型Ordinary Share

年結日Sep 04

公司地址333 Ludlow Street

城市STAMFORD

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編06902

電話18887291206

網址https://sema4.com/

公司代碼WGS

上市日期Sep 04, 2020

成立日期2020

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Keith A. Meister

Independent Director

20.13K

+179.38%

Mr. Kevin Feeley

Chief Financial Officer

9.13K

+121.71%

Dr. Bryan Dechairo

Chief Operating Officer

Ms. Katherine A. Stueland

Chief Executive Officer, Director

Mr. Jason Michael Ryan, CPA

Chairman of the Board

Mr. Eli D. Casdin

Independent Director

Mr. Richard C. (Rick) Pfenniger, Jr.

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Keith A. Meister

Independent Director

20.13K

+179.38%

Mr. Kevin Feeley

Chief Financial Officer

9.13K

+121.71%

Dr. Bryan Dechairo

Chief Operating Officer

Ms. Katherine A. Stueland

Chief Executive Officer, Director

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Patients with third party insurance

234.70M

76.84%

Institutional customers

65.11M

21.32%

Other

3.29M

1.08%

Self pay patients

2.34M

0.77%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Patients with third party insurance

234.70M

76.84%

Institutional customers

65.11M

21.32%

Other

3.29M

1.08%

Self pay patients

2.34M

0.77%

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

Casdin Capital, LLC

12.36%

Corvex Management LP

10.19%

Fidelity Management & Research Company LLC

9.29%

Icahn School of Medicine at Mount Sinai

4.81%

OPKO Health Inc

4.80%

Other

58.54%

持股股東

佔比

Casdin Capital, LLC

12.36%

Corvex Management LP

10.19%

Fidelity Management & Research Company LLC

9.29%

Icahn School of Medicine at Mount Sinai

4.81%

OPKO Health Inc

4.80%

Other

58.54%

股東類型

持股股東

佔比

Hedge Fund

34.94%

Investment Advisor/Hedge Fund

30.52%

Investment Advisor

30.22%

Corporation

10.79%

Research Firm

5.64%

Individual Investor

1.54%

Pension Fund

1.15%

Bank and Trust

0.39%

Sovereign Wealth Fund

0.29%

機構持股

更新時間: 3月4日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

362

28.77M

101.81%

-353.08K

2024Q4

341

29.17M

104.22%

+1.72M

2024Q3

289

26.18M

97.50%

+377.48K

2024Q2

262

24.98M

95.33%

+588.25K

2024Q1

260

22.13M

86.19%

+1.41M

2023Q4

271

20.57M

80.67%

-567.28K

2023Q3

283

21.68M

85.29%

-751.02K

2023Q2

291

21.85M

86.03%

-864.88K

2023Q1

296

21.58M

684.27%

+3.47M

2022Q4

305

9.98M

86.27%

+851.42K

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Casdin Capital, LLC

3.51M

12.5%

Dec 31, 2024

Corvex Management LP

2.47M

8.81%

Dec 31, 2024

Fidelity Management & Research Company LLC

402.39K

1.43%

+348.57K

+647.59%

Dec 31, 2024

Icahn School of Medicine at Mount Sinai

1.37M

4.89%

-1.35M

-49.50%

Feb 21, 2025

OPKO Health Inc

1.37M

4.88%

-800.83K

-36.88%

Nov 20, 2024

Summit Partners Public Asset Management, LLC

1.43M

5.08%

+671.40K

+88.86%

Feb 05, 2025

William Blair Investment Management, LLC

670.00K

2.39%

+508.67K

+315.31%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

1.08M

3.85%

+90.95K

+9.20%

Dec 31, 2024

Goldman Sachs & Company, Inc.

1.06M

3.79%

+34.15K

+3.32%

Dec 31, 2024

The Vanguard Group, Inc.

1.00M

3.58%

+156.77K

+18.51%

Dec 31, 2024

持股ETF

更新時間: 6月6日週五

機構名稱

佔比

Global X Genomics & Biotechnology ETF

2.15%

Simplify Health Care ETF

2.12%

SPDR S&P Health Care Services ETF

1.55%

Harbor Health Care ETF

1.41%

Hypatia Women CEO ETF

0.54%

First Trust Small Cap Growth AlphaDEX Fund

0.53%

Franklin Genomic Advancements ETF

0.38%

First Trust Active Factor Small Cap ETF

0.34%

iShares U.S. Healthcare Providers ETF

0.26%

First Trust Small Cap Core Alphadex Fund

0.26%

Global X Genomics & Biotechnology ETF

佔比2.15%

Simplify Health Care ETF

佔比2.12%

SPDR S&P Health Care Services ETF

佔比1.55%

Harbor Health Care ETF

佔比1.41%

Hypatia Women CEO ETF

佔比0.54%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.53%

Franklin Genomic Advancements ETF

佔比0.38%

First Trust Active Factor Small Cap ETF

佔比0.34%

iShares U.S. Healthcare Providers ETF

佔比0.26%

First Trust Small Cap Core Alphadex Fund

佔比0.26%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

Apr 28, 2023

Merger

33<1

Apr 28, 2023

Merger

33<1

Apr 28, 2023

Merger

33<1

Apr 28, 2023

Merger

33<1

公告日期

類型

比率

Apr 28, 2023

Merger

33<1

Apr 28, 2023

Merger

33<1

Apr 28, 2023

Merger

33<1

Apr 28, 2023

Merger

33<1

KeyAI



GeneDx Holdings Corp

90.900USD

GeneDx Holdings Corp

90.900

概覽

公司